Skip to main content

Table 1 Clinical characteristics of patients

From: Clinical study of harvesting lymph nodes with carbon nanoparticles in advanced gastric cancer: a prospective randomized trial

Variable

Pattern group

Experimental group

Control

p value*

Sex

Male

10 (9.5)

9 (9.5)

0.705

Female

5 (5.5)

6 (5.5)

 

Age (years)

>70

2 (1.5)

1 (1.5)

 

50–70

11 (9.5)

8 (9.5)

0.380

<50

2 (4.0)

6 (4.0)

 

BMI

 

25.45 ± 3.60

23.80 ± 2.44

0.155

Lauren type

Intestinal

3 (3.0)

3 (3.0)

 

Nonintestinal

12 (12.0)

12 (12.0)

1.000

Location

Upper

5 (4.5)

4 (4.5)

 

Middle

2 (3.0)

4 (3.0)

0.788

Lower

8 (7.5)

7 (7.5)

 

Surgery

DSG

7 (7.0)

7 (7.0)

 

TG

8 (8.0)

8 (8.0)

1.000

Stage

IB

0 (1.0)

2 (1.0)

 

II

5 (6.0)

7 (6.0)

0.242

III

10 (8.0)

6 (8.0)

 

Operation time (min)

 

214.7 ± 42.9

212.9 ± 55.7

0.922

Bleeding (mL)

 

110.0 ± 63.2

98.7 ± 66.2

0.635

Complication

Yes

5 (4.0)

3 (4.0)

 

No

10 (11.0)

12 (11.0)

0.682

  1. *Analyzed by Student’s t test or the χ 2 test